Z hu Baoguo is the chairman of Joincare Pharmaceutical Group and its subsidiary, Livzon Pharmaceutical Group. He started his business career in the early 1990s with a hit product, "Taitai Oral Liquid," a herbal tonic for women based on a traditional recipe he acquired. Leveraging the immense success of this health supplement, he transformed the company into a comprehensive modern pharmaceutical empire specializing in prescription drugs and diagnostic reagents.
A chemical engineer by training, Zhu has diversified his interests beyond healthcare. He was a founding shareholder of WeBank, China's first digital-only bank backed by Tencent, demonstrating his foresight in the fintech sector. Based in Shenzhen, Zhu is one of China's most resilient entrepreneurs, having successfully navigated the transition from traditional health products to R&D-driven biopharmaceuticals.
Advertisement
Zhu Baoguo is a Chinese businessman, the chairman of Shenzhen-based Joincare Pharmaceutical Group Industry (SHA: 600380).
Prior to his pharmaceutical venture, Zhu was a chemical engineer with a bachelor's degree in chemistry from the Henan Normal University. Joincare began with a unique product: making herbal tonics for women, which were based on a recipe Zhu bought from a Chinese medicine practitioner in his native Henan province.
Zhu Baoguo's career is defined by his successful application of his technical background to the massive pharmaceutical market. His structural achievement is tied to expanding Joincare from a single herbal tonic into a pharma empire with businesses in prescription drugs, traditional Chinese medicines, health products and diagnostic reagents.
Zhu has diversified his wealth into fintech, owning a stake in WeBank, a Chinese digital bank backed by Tencent.
Advertisement
Trained as a chemical engineer.
Founded Joincare, starting with herbal tonics.
Holds a stake in WeBank, a Chinese digital bank.
Zhu Baoguo's wealth is concentrated in his controlling stake in the publicly traded pharmaceutical giant, Joincare Pharmaceutical Group Industry, and his fintech investments.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+3.1% | +$171.84M
-0.02% | -$0.44M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content